01:32 PM EST, 11/07/2025 (MT Newswires) -- Health care stocks declined Friday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each shedding about 0.5%.

The iShares Biotechnology ETF (IBB) fell 1.6%.

In corporate news, Gilead Sciences ( GILD ) shares fell 3.6% after the firm said a phase 3 trial comparing its drug Trodelvy with chemotherapy as a first-line treatment post-endocrine therapy in HR+/HER2-negative metastatic breast cancer did not meet the primary endpoint of progression-free survival.